Neuropathic pain in humans results from an injury or disease of the somatosensory nervous
system at the peripheral or central level. Despite the considerable progress in pain …

Because of their localized activity and low systemic absorption, topical analgesics have a
favorable safety profile and a low risk for drug-drug interactions. There is a growing body of …

Neuropathic pain in humans arises as a consequence of injury or disease of somatosensory
nervous system at peripheral or central level. Peripheral neuropathic pain is more common …

Introduction: Neuropathic pain (NP) is a particularly severe and intractable chronic condition
that is not well treated by commonly recommended systemic pharmacological therapies …

Topical analgesics applied locally to skin or to specialized compartments modify pain by
actions on sensory nerve endings and/or adjacent cellular elements. With this approach …

Peripheral neuropathic pain (PNP), neuropathic pain that arises from a damage or disease
affecting the peripheral nervous system, is associated with an extremely large disease …

The goal of our review was to emphasize important aspects that physicians should take into
consideration when prescribing topical analgesics as part of chronic neuropathic pain …

Background: The current medical treatment of neuropathic pain (NP) is inadequate with
more than two thirds of patients having no suitable solution for their morbid disease and …

Neuropathic pain develops from a lesion or disease affecting the somatosensory system.
Translational investigations of neuropathic pain by using different animal models reveal that …

Objectives: The study intended to identify objective biomarkers in PHN skin on a patient-by-
patient personalized medicine platform. The totality of biopsy biomarker data can provide a …